Dr. Carpten serves as professor and chair, Department of Translational Genomics and director, Institute for Translational Genomics, USC Keck School of Medicine. His expertise spans a broad range of research disciplines, including germline genetics, tumor profiling, cancer cell biology, functional genomics, and health disparities. His research aims to discover molecular alterations in cancer and translate these findings into new approaches for prevention, diagnosis, and treatment. His program investigates the development and application of cutting-edge technologies and novel bioinformatics approaches for discovery research. His work has impacted our understanding of a variety of cancer types: prostate, breast, colon, brain, pediatric, and multiple myeloma. Dr. Carpten has co-authored over 200 peer-reviewed articles in journals including Science, Nature, Nature Genetics, Cancer Cell, Cancer Research, Molecular Cancer Therapeutics, and The New England Journal of Medicine. In 2021, he was elected as a Fellow of the AACR Academy, and serves on the NCI Board of Scientific Counselors and the Scientific Advisory Board for Break Through Cancer. He received his PhD in molecular, cellular, and developmental biology from The Ohio State University.